$295 Million is the total value of WILKINS INVESTMENT COUNSEL INC's 75 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 8.3% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
NEM | Buy | Newmont Mining | $13,070,000 | +48.4% | 334,100 | +0.8% | 4.42% | +37.0% |
MRK | Buy | Merck | $11,882,000 | +9.7% | 206,254 | +0.8% | 4.02% | +1.3% |
PG | Buy | Procter & Gamble | $10,355,000 | +3.6% | 122,298 | +0.7% | 3.51% | -4.4% |
INTC | Buy | Intel | $9,500,000 | +1.8% | 289,627 | +0.4% | 3.22% | -6.0% |
PFE | Buy | Pfizer | $8,991,000 | +19.7% | 255,340 | +0.8% | 3.04% | +10.5% |
DOW | Buy | Dow Chemical | $8,605,000 | -1.4% | 173,095 | +0.8% | 2.91% | -9.0% |
BP | Buy | BP P.L.C. | $8,155,000 | +33.4% | 229,642 | +13.4% | 2.76% | +23.1% |
ESRX | Buy | Express Scripts | $7,822,000 | +11.8% | 103,187 | +1.3% | 2.65% | +3.2% |
NVS | Buy | Novartis AG (ADR) | $7,768,000 | +18.6% | 94,150 | +4.1% | 2.63% | +9.5% |
SLB | Buy | Schlumberger Ltd | $7,623,000 | +11.6% | 96,400 | +4.1% | 2.58% | +3.1% |
LLTC | Buy | Linear Technology | $6,981,000 | +5.3% | 150,035 | +0.9% | 2.36% | -2.8% |
FFIV | Buy | F5 Networks | $6,279,000 | +15.8% | 55,160 | +7.7% | 2.13% | +6.9% |
EMR | Buy | Emerson Electric | $5,359,000 | -2.3% | 102,740 | +1.9% | 1.81% | -9.8% |
XOM | Buy | Exxon Mobil | $4,908,000 | +12.4% | 52,362 | +0.2% | 1.66% | +3.7% |
TRMB | Buy | Trimble Navigation | $4,261,000 | -0.9% | 174,925 | +0.9% | 1.44% | -8.4% |
AZPN | Buy | Aspen Technology, Inc | $1,982,000 | +17.3% | 49,250 | +5.3% | 0.67% | +8.4% |
DIS | Buy | Walt Disney | $1,810,000 | -1.2% | 18,500 | +0.3% | 0.61% | -8.8% |
CMCSA | Buy | Comcast Corp | $1,441,000 | +7.2% | 22,100 | +0.5% | 0.49% | -1.0% |
FAST | Buy | Fastenal | $1,256,000 | -5.1% | 28,300 | +4.8% | 0.42% | -12.4% |
UNP | Buy | Union Pacific | $1,045,000 | +15.5% | 11,975 | +5.3% | 0.35% | +6.6% |
HD | Buy | Home Depot | $779,000 | -2.7% | 6,103 | +1.7% | 0.26% | -10.2% |
ANSS | New | Ansys Inc. | $701,000 | – | 7,725 | +100.0% | 0.24% | – |
CVX | Buy | Chevron | $562,000 | +12.4% | 5,365 | +2.4% | 0.19% | +3.8% |
BMY | Buy | Bristol Myers Squibb | $432,000 | +16.1% | 5,867 | +0.9% | 0.15% | +7.4% |
CHTR | New | Charter Communications | $337,000 | – | 1,473 | +100.0% | 0.11% | – |
AGN | Buy | Allergan | $258,000 | -9.5% | 1,115 | +4.7% | 0.09% | -17.1% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-08-10
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Merck | 42 | Q3 2023 | 5.7% |
Newmont Mining | 42 | Q3 2023 | 7.2% |
Procter & Gamble | 42 | Q3 2023 | 4.9% |
Intel | 42 | Q3 2023 | 5.0% |
Johnson & Johnson | 42 | Q3 2023 | 3.7% |
International Flavors & Fragra | 42 | Q3 2023 | 4.2% |
Automatic Data Processing | 42 | Q3 2023 | 3.9% |
Sysco | 42 | Q3 2023 | 4.2% |
Northern Trust | 42 | Q3 2023 | 4.0% |
Novartis AG (ADR) | 42 | Q3 2023 | 3.7% |
View WILKINS INVESTMENT COUNSEL INC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-12 |
13F-HR | 2023-11-09 |
13F-HR | 2023-08-07 |
13F-HR | 2023-05-08 |
13F-HR | 2023-02-07 |
13F-HR | 2022-11-08 |
13F-HR | 2022-08-08 |
13F-HR | 2022-05-10 |
13F-HR | 2022-02-10 |
13F-HR | 2021-11-09 |
View WILKINS INVESTMENT COUNSEL INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.